MedTrace Logo

CapsoCam® Colon Capsule Endoscope (CCE) Compared to Colonoscopy (OC)

NCT04246632 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2021-08-06

No results posted yet for this study

Summary

This non-significant risk pilot study is designed to evaluate safety and performance of the CapsoCam® Colon capsule endoscope in patients who meet the eligibility criteria and are scheduled for colonoscopy.

Conditions

  • Colonoscopy

Interventions

DEVICE

CapsoCam Colon Capsule Endoscopy

CapsoCam® Colon is intended to provide visualization of the colon and the detection of colon polyps in adults.

Sponsors & Collaborators

  • Capso Vision, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-25
Primary Completion
2021-02-25
Completion
2021-03-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04246632 on ClinicalTrials.gov